Related Experiment Video
Updated: Jan 30, 2026

Application of Ultrasound and Shear Wave Elastography Imaging in a Rat Model of NAFLD/NASH
Published on: April 20, 2021
[Progress in the Management of NAFLD/NASH]
Non-alcoholic fatty liver disease (NAFLD) is a common liver condition linked to metabolic syndrome. Lifestyle changes and new drugs like obeticholic acid show promise for managing non-alcoholic steatohepatitis (NASH).
Area of Science:
- Hepatology
- Gastroenterology
- Metabolic Diseases
Background:
- Non-alcoholic fatty liver disease (NAFLD) encompasses simple steatosis (NAFL) to non-alcoholic steatohepatitis (NASH) and cirrhosis.
- NAFLD is a hepatic manifestation of metabolic syndrome, strongly associated with insulin resistance.
- Key factors in NAFLD/NASH development include adiponectin, TNF-alpha, gut microbiota, and genetic susceptibility (PNPLA3, MTHFR).
Purpose of the Study:
- To review recent advances in the epidemiology, etiology, diagnosis, and treatment of NAFLD/NASH.
- To highlight the roles of metabolic factors, genetics, and gut microbiota in NAFLD.
- To discuss current and emerging therapeutic strategies for NAFLD and NASH.
Main Methods:
- Literature review of recent scientific advancements in NAFLD/NASH.
- Analysis of diagnostic criteria including liver biopsy, Matteoni's classification, and Brunt's staging.
- Evaluation of prevention strategies and pharmacological treatments.
Main Results:
- NAFLD diagnosis relies on liver biopsy, with staging based on established classifications.
- Lifestyle modifications (diet, exercise) are crucial for prevention and treatment.
- Current pharmacotherapies (vitamin E, pioglitazone, liraglutide) have limitations, but obeticholic acid shows promise for NASH.
Conclusions:
- NAFLD is a complex condition with multifactorial etiology.
- Effective management requires lifestyle changes and potentially novel pharmacotherapies.
- Obeticholic acid represents a promising therapeutic option for NASH.
More Related Videos
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tonsillitis II: Management
Impression Management Techniques I: Managing Appearances
Managing Impressions
Management of Insomnia